Skip to the content

Monash stem cell scientists first to receive California grants

21 May 2009

Stem cell scientists from the Monash University, the Australian Stem Cell Centre, and the Florey Neuroscience Institutes are the first recipients of collaborative grants under the Victoria-California Stem Cell Alliance.

Four collaborative stem cell projects involving Monash researchers are the first to be funded under the International Alliance between the State of Victoria and the California Institute of Regenerative Medicine (CIRM).

The projects were announced today by Victoria's Minister for Innovation, Gavin Jennings at the BIO2009 conference in Atlanta, Georgia.

The research focus of these projects varies from studying the immune system in conjunction with stem cells to prevent rejection, to harnessing the abilities of human embryonic stem cells and induced pluripotent stem cells (iPS cells) and their potential for growth and differentiation into all the cells of the body.

Monash University's Faculty of Medicine, Nursing and Health Sciences is involved in three of the projects.  Recipients announced today are:

  • Andrew Elefanty and Ed Stanley, Monash University, with Novocell Inc.
    Methods for detection and elimination of residual human embryonic stem cells in a differentiated cell product.
  • Richard Boyd, Monash Immunology and Stem Cell Laboratories and Australian Stem Cell Centre, with the University of California, Irvine
    Neural Stem Cells as a Developmental Candidate to Treat Alzheimer's Disease.
  • Andrew Laslett, Department of Anatomy and Developmental Biology at Monash University and the Australian Stem Cell Centre, with Scripps Research Institute
    Ensuring the safety of cell therapy: a quality control pipeline for cell purification and validation.

Monash University's Faculty of Pharmacy and Pharmaceutical Sciences is also the recipient of Victoria – CIRM funding:

  • Clare Parish and Colin Pouton, Monash University and Florey Neuroscience Institutes, with Burnham Institute for Medical Research
    Developmental Candidates for Cell-Based Therapies for Parkinson's Disease.

University's Deputy Vice Chancellor (Research), Professor Edwina Cornish, welcomed today's announcement by the Minister. "Monash is an internationally focused university that supports intricate research programs on the most pressing biomedical issues. These exciting joint projects with California are a triumph of collaboration between the brightest experts in the world that will help to tackle a range of debilitating illnesses," she said.


Prof Richard Boyd

Professor Richard Boyd